• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Budd-Chiari syndrome in children: Challenges and outcome

    2023-12-05 07:17:00ArghyaSamantaMoinakSenSarmaRajanikantYadav
    World Journal of Hepatology 2023年11期

    Arghya Samanta,Moinak Sen Sarma,Rajanikant Yadav

    Abstract Budd-Chiari syndrome (BCS) is an uncommon disease of the liver,characterised by obstruction of the hepatic venous outflow tract.The etiological spectrum of BCS as well as venous obstruction pattern show wide geographical and demographic variations across the globe.Compared to adults with BCS,children have primary BCS as the predominant etiology,earlier clinical presentation,and hence better treatment outcome.Underlying prothrombotic conditions play a key role in the etiopathogenesis of BCS,though work-up for the same is often unyielding in children.Use of next-generation sequencing in addition to conventional tests for thrombophilia leads to better diagnostic yield.In recent years,advances in radiological endovascular intervention techniques have revolutionized the treatment and outcome of BCS.Various non-invasive markers of fibrosis like liver and splenic stiffness measurement are being increasingly used to assess treatment response.Elastography techniques provide a novel non-invasive tool for measuring liver and splenic stiffness.This article reviews the diagnostic and therapeutic advances and challenges in children with BCS.

    Key Words: Budd-Chiari syndrome;Radiological endovascular intervention;Transjugular intrahepatic porto-systemic shunt;Direct intrahepatic porto-systemic shunt;Liver stiffness;Splenic stiffness;Shear-wave elastography

    INTRODUCTION

    Budd-Chiari syndrome (BCS) is a rare vascular disease of the liver with a promising outcome if treated optimally on time.It occurs due to obstruction in the hepatic venous outflow anywhere from the hepatic vein (HV) to the entry of the inferior vena cava (IVC) to the heart[1].Involvement of at least two HV leads to an increase in hepatic sinusoidal pressure and congestion resulting in symptoms of BCS[2].Global epidemiological data on BCS is scarce[3].The incidence of BCS reported in the published literature ranges from 0.2 to 4.1 cases per million population per year,with an estimated prevalence of 2.4-7.7 per million population in Asian countries[4,5] and of 1.4-4.0 per million population in Western countries[6-9].Population-based study on the epidemiology of BCS in children is lacking.Large case series on pediatric BCS are available[10-15].Chronic BCS constitutes 3%-7% of cases of portal hypertension (PHTN) in the pediatric population[10,11].So far,interventional and long-term outcome studies in children are limited[12-15].Over the years there has been remarkable progress in understanding the evolution of this disease.This review aims to discuss the various aspects of BCS,including recent updates on diagnostic and treatment modalities for BCS in children as well as the challenges in them.The review will particularly focus on chronic BCS which accounts for the majority of cases in children.

    VARIATIONS IN THE ETIOLOGICAL SPECTRUM OF BCS

    Primary BCS is an obstruction of the hepatic venous outflow tract that occurs due to an endoluminal venous lesion(thrombosis or web) resulting from an unidentifiable cause or an inherent prothrombotic condition.Secondary BCS results from obstruction from an invasive lesion (malignant tumor or a parasitic mass) or extrinsic compression by spaceoccupying lesions (abscesses,cysts,and benign or malignant solid tumors)[1].The above inflammatory or neoplastic conditions can also result in a secondary prothrombotic state which further adds to thrombosis in the HV.Secondary causes of BCS are common in adults as compared to children[16].Global variations in the type of BCS may reflect different predisposing factors in different countries.Studies from Western countries have shown HV to be the most common site of obstruction in BCS[17,18].There seems to be a shift in the pattern of obstruction in studies from Asian countries.Earlier,isolated IVC obstruction was the most type of BCS in Asian patients.Recent studies from China[19,20]as well as India[16,21,22] have noted that a combined IVC and HV obstruction (40%-75%) is the most common type of BCS.A similar pattern has also been documented in Indian children with BCS[12-15].Over the years,the changes in the spectrum have been better documented due to the advancements in radiology such as high-resolution Doppler ultrasonography (DUS) and non-invasive venography by computed tomography (CT),and magnetic resonance imaging.

    BCS AND THROMBOPHILIA

    Primary BCS is often regarded as a result of a unique constellation of prothrombotic conditions.The inherited prothrombotic conditions associated with BCS are protein C deficiency,protein S deficiency,antithrombin III deficiency,factor V Leiden mutation,prothrombin gene mutation,and hyper-homocysteinemia with methyltetrahydrofolate reductase mutation[23].Acquired prothrombotic conditions like antiphospholipid syndrome (APLS),paroxysmal nocturnal hemoglobinuria (PNH),sickle cell disease,and myeloproliferative disorders (MPD) also predispose to BCS[24,25].Systemic disorders like inflammatory bowel disease,Behcet’s disease,and other inflammatory intraabdominal lesions can cause BCS in adults but rarely in children[26].Recent studies reported an identifiable etiology in 80-84% of cases in adults[27-30].Underlying myeloproliferative disorders (45%-51%) and exposure to oral contraceptives (50%) are the commonest etiologies[27,28].In over 25% of cases,more than one thrombophilic state may be present[29,30].From the available pediatric literature,we understand that the prothrombotic workup in children is often unyielding,inconclusive,or ambiguous.Table 1 summarizes the findings of prothrombotic workup of prior pediatric studies on BCS[11-14,31-35].As shown,most of the pediatric publications are from India including authors’ own experience.One of the majordrawbacks is the lack of in-depth testing for prothrombotic conditions.Shuklaet al[32] found thrombophilia in 42% of children and 37% of adolescents.The commonest etiologies were Factor V Leiden in children and JAK 2V617F mutation in adolescents.Although thrombophilia may be present in 68%-75% of children,the cause-and-effect relationship is not established[12,32].Relative and multiple deficiencies of proteins C and S,antithrombin III deficiency,and hyperhomocysteinemia (9%-15%) may be a result of an advanced liver disease resulting in poor synthetic function of the liver rather than a true thrombophilia state[29].In a systematic review of adults with BCS,MPD was found to be more associated with HV block (16%-62%) than IVC block (4%-5%)[36].

    Table 1 Summary of various pediatric studies (national) of thrombophilia profile in children with Budd-Chiari syndrome

    Oral anticoagulants may alter proteins C and S,activated protein C levels,and lupus anticoagulant levels.Hence these tests are best performed before starting thromboprophylaxis.Further,the presence of hypersplenism and hemodilution in cirrhosis with portal hypertension masks the peripheral blood findings of a concomitant MPD[29].Genetic testing is the gold standard for documentation of thrombophilia.In a study of 80 adults with non-cirrhotic splanchnic vein thrombosis,next-generation sequencing was able to identify JAK2 mutations,previously undetected by conventional techniques in one-third of cases[37].

    It is also suggested that the prevalence of various thrombophilic disorders is different between younger children and adolescents.In a study from India,the JAK2V617F was found to be common in adolescents but not in children[32].Recently it has been shown that adolescent venous thromboembolism is multifactorial in the majority with more than two risk factors at diagnosis[38].Warfarin is the most commonly used oral anticoagulant in BCS patients,especially after radiological intervention.As it has a narrow therapeutic window,the dose needs to be titrated with regular monitoring of international normalized ratio (INR) (target: 2-3).Vitamin K epoxide reductase complex subunit C1 (VKORC1) and cytochrome P450 2C9 (CYP2C9) are the two major genes involved in the metabolism of warfarin and they determine the dose requirement of warfarin[39].CYP2C9 metabolizes the more potent S-enantiomer of warfarin while VKORC1 is the target protein for warfarin.Multiple single nucleotide polymorphisms have been described in these genes,of which the most important ones are CYP2C9*2,CYP2C9*3,and VKORC1 heterozygous haplotype GA and homozygous AA[40].Thus,the patient’s genotype is a major determinant of not only the dose requirement but also the risk of anticoagulationrelated complications.In a study from India in adults with BCS,patients with the presence of mutations in VKORC1 or CYP2C9 were associated with an increased risk of bleeding[41].More intensive monitoring while on warfarin is recommended for these patients.Some guidelines have now started recommending incorporating the results of genetic testing for clinical use while on warfarin therapy[42].

    Identification of thrombophilia in a child has implications in terms of the need for lifelong oral anticoagulation,increased risk of other venous thromboembolic events,lifestyle modifications like avoiding oral contraceptive pills,risk of complications like leukemia in myeloproliferative disorders,and implications for other family members.In addition,there is a need to educate asymptomatic family members regarding the risk factors and lifestyle modifications.

    CLINICAL FEATURES

    Clinical manifestations can be diverse,ranging from acute liver failure to completely asymptomatic patients,making BCS a possible differential diagnosis in many acute and chronic liver diseases.Most patients with BCS have a chronic presentation,whereas only a small number of patients present with a fulminant type of BCS[12-14].The clinical and radiological features of children with BCS in various pediatric studies are summarized in Table 2.The usual age at presentation in children is 10 (range 1.5-17) years but BCS has been reported in children as young as 4.5 mo[11,12,32].The commonest symptom is rapidly reaccumulating ascites (83%-90%) with dilated tortuous abdominal and back veins (60%-70%)[11-14,31].Up to 15%-20% of patients can be completely asymptomatic,hence a high index of suspicion should be kept,especially when there is no clear detectable etiology for chronic liver disease and/or a prothrombotic condition exists[43].In such scenarios,proper imaging by an experienced radiologist is warranted[44].The presentation of BCS depends on the extent and rapidity of hepatic venous outflow obstruction and the development of decompressing venous collaterals.With this concept,BCS can be classified as fulminant,acute,subacute,or chronic[45,46].However,a pathological examination of the liver illustrates a dissociation between the rapidity of the clinical presentation and the acuteness of the histological damage.Up to 50% of patients clinically classified as acute have histological features of chronicity (e.g.,fibrosis or cirrhosis)[46].The prognostic value of this clinical classification in predicting mortality has not been prospectively evaluated[47].Over time,several prognostic indices have been designed to predict mortality and response to therapeutic interventions[15,18,46,47].These scoring systems incorporate clinical and laboratory features to stratify patients,although their use for the management of an individual patient is debatable[48].

    Table 2 Clinical presentation,site of block,radiological intervention,and outcomes of major studies in children with Budd-Chiari syndrome

    DIFFERENCE BETWEEN ADULTS AND CHILDREN WITH BCS

    BCS can occur at any age group but it most commonly affects young adults.In adults,secondary causes of BCS are much more frequently seen than children in whom primary causes are predominant.Regarding the underlying etiology,thrombophilic conditions are reported in more than 80% of adults with BCS.In Asian children,the etiology is largely idiopathic.Thrombophilia work-up is often under-reported and the results are variable.Acquired prothrombotic conditions like MPD,APLS,PNH,sickle cell disease,and oral contraceptive pill use are predominantly seen in adults.On the contrary,inherited thrombophilias like protein C deficiency and protein S deficiency are more commonly found in children.The clinical presentation is also different for adults and children.Shuklaet al[32] compared 43 children and 129 adult patients with BCS.They found hepatomegaly without ascites as the most common presentation in children as compared to ascites being the most common presentation in adults.The authors hypothesized that children have better angiogenesis and collateral formation,and shorter disease duration,leading to milder clinical presentation and better treatment outcome.

    DIAGNOSTIC CHALLENGES

    The diagnosis of BCS depends on the demonstration of HV and/or IVC obstruction.Invasive venography remains the gold standard;however,it is performed during the time of endovascular intervention procedure.DUS has therefore emerged as the primary imaging modality with a diagnostic accuracy of > 90%[12,13,15].DUS evaluates hepatic,portal,and IVC patency,site,and length of block and liver parenchymal changes (including caudate lobe hypertrophy and intrahepatic comma-shaped collaterals).HVs may be engorged,irregular,or filled with thrombus.The “health” and residual stump of the HV are the most critical to plan an endovascular intervention.Triphasic flow may be dampened or reversed.The IVC may be narrowed or displaced by caudate hypertrophy or contain an intraluminal thrombus.Intrahepatic comma-shaped collaterals and caudate lobe hypertrophy are almost universally seen in patients with BCS.The presence of dense intrahepatic collaterals suggests chronicity.Subcapsular collaterals may bleed during a percutaneous intervention and need to be carefully documented.Non-invasive venography (CT or MRI) is required when there is a diagnostic ambiguity.Hypoenhancement of the peripheral hepatic parenchyma and relatively normal enhancement of the caudate lobe result in a mottled appearance on CT.These changes are more obvious on MRI[49].However,if they are unyielding,invasive venography and liver biopsy should be considered.

    Another challenging diagnostic dilemma in the context of BCS is hepatocellular carcinoma (HCC).Long-standing congestion and fibrosis of hepatic parenchyma in patients with chronic BCS are known to give rise to hepatic nodules.The etiology of hepatic nodules detected on radio imaging in BCS patients can be benign regenerative nodules and HCC.It is important to distinguish between these two conditions as treatment differs significantly.HCC lesions are usually larger in size (> 2 cm) and hypervascular on DUS and CT/MR[50].Also,for HCC,contrast enhancement in T1-weighted MR imaging can show different enhancement patterns between HCC with and without BCS[51].Yanget al[51],in a comparative study between 10 adult HCC patients with associated primary BCS and 32 other HCC patients without BCS,found that significantly more lesions with BCS were hyperintense during the arterial phase and slightly hyperintense or isointense during the venous phase than lesions without BCS (P< 0.05 for both).Therefore,histological confirmation is required in the workup of HCC in patients with BCS.

    TREATMENT OPTIONS

    Therapeutic options for BCS include medical management with anticoagulation therapy,radiological interventions such as angioplasty and stenting,surgical shunting and transjugular intrahepatic portosystemic shunt (TIPSS),and lastly,liver transplantation (LT).

    Medical therapy

    Anticoagulation alone with oral anticoagulants is sufficient in only 10% of adult patients,especially those with mild disease,and the vast majority of them progress,requiring intervention strategies in follow-up[52-54].Pediatric experience is limited.Sharmaet al[14] reported a 33% response in a small cohort of Indian BCS children who were treated with warfarin alone.Data on the comparative efficacy of directly acting anticoagulantsvsvitamin K antagonists in BCS patients is scarce[55].A recent Austrian multicentre study on the efficacy and safety of DOAC in 22 adult BCS patients(DOAC first-line anticoagulation in 6,switched over from warfarin and LMWH in 16) showed that DOAC showed clinical response in 63% of cases while bleeding occurred in 11 (4 major bleeding,7 minor bleeding)[55].Confirmation of efficacy and safety by larger prospective studies is needed.

    Radiological endovascular intervention

    The progressive improvement in radiological endovascular intervention (REI) techniques in the past two decades has provided better procedural and clinical success for BCS treatment compared to other treatment modalities in both adults and children[14,15,56,57].

    Angioplasty vs stenting

    The rationale of angioplasty is to decompress the liver while restoring hepatic blood flow.Angioplasty can be done with or without stenting in BCS patients with short-segment stenosis (< 5 cm).Wanget al[58],in a landmark study,compared the treatment efficacy and long-term patency of angioplasty with and without stenting in 88 adult Chinese patients with BCS.They had shown that the superiority of angioplasty with stenting over angioplasty alone in the rate of re-stenosis(2%vs40% over a median follow-up period of 27 mo,P< 0.0001)[58].Balloon angioplasty without stenting of the obstructed veins is preferred in infants and younger children as appropriate sizes of stents are not available,thus making stenting technically difficult in this population.Also due to the relatively shorter duration of disease,the veins are likely to be much more pliant.Hence angioplasty alone may reduce and normalize the venous pressure significantly after the procedure.In older children,angioplasty alone has a technical success rate and clinical response rate of 90% but is fraught with a high risk of blockage[11-15].Restenosis is almost always inevitable.Nagralet al[12],Kathuriaet al[13],and Sharmaet al[14] have reported higher re-occlusion rates with angioplasty alone (75%,33%,and 57%,respectively) compared to angioplasty+stenting (0%,13%,and 33%,respectively) and TIPSS (20%,33%,and 28%,respectively).This highlights that angioplasty with stenting rather than angioplasty alone,should be the preferred modality of radiological intervention(RI) in children.The smaller size of the liver and caliber of the veins in children pose a challenge when choosing an appropriate size and length of the stent.An uncovered self-expandable metallic stent is preferred over fully covered stents because of the lower risk of post-procedural thrombosis.Longer stents (20-30 mm) are required for long-segment IVC blocks than HV blocks.Overall,the technical success and clinical response rate of stenting in children is excellent (>90%) with a much less re-stenosis rate than angioplasty[11-15].In the authors’ experience,the length of the stent may appear longer as the liver decongests after the intervention.However,with the growth of the child,the liver also grows in size and the final stent size is usually appropriate for the child.Customized stents are available.It is also important to realize that once the liver is recovering and the physiology is restored,there is an expected sudden growth spurt in children with chronic liver disease,especially during puberty.With growth,the blood flow and turbulence through the recovering liver increase.Hence anticoagulation is most important in this phase till the stent undergoes complete endothelialization.Oral contraceptives in adolescence are to be prescribed with caution.

    TIPSS

    TIPSS is a shunt created between the portal and the systemic circulation,leading to a reduction in hepatic congestion and symptom resolution.Currently,TIPSS is performed in failed angioplasty-stenting with an available HV stump and as a bridge to LT[27].TIPSS is technically more demanding than cirrhotic patients due to the blocked HVs.Nonetheless,various studies have established TIPSS as a safe and effective treatment for BCS in adults[22,48,59,60].Amarapurkaret al[22] and Shalimaret al[59] have shown good technical success rates (87.5%-100%) and clinical success rates (80%-93%).Post-procedure encephalopathy occurs less frequently (3% to 5% cases) than in other cirrhotic patients,reflecting the relatively preserved hepatic function in most patients with BCS[59,60].The main concern about TIPSS is the higher occurrence of stent dysfunction.Compared to other cirrhotic patients undergoing TIPSS,BCS patients show higher stent dysfunction (70%vs50% within 1 year),probably due to underlying prothrombotic conditions in BCS[61].The advent of polytetrafluoroethylene covered stents has dramatically reduced the incidence of stent dysfunction (30%-70% in bare stentsvs10-20% in covered stents)[61,62].The available TIPSS stents are usually expensive and are inappropriate in terms of sizes for children,thus limiting their use in the pediatric population,although reports of successful treatment of children with BCS with TIPSS are available[12,13].TIPSS in children with BCS risks placement of the bare end of the stent beyond the portal vein and into the superior mesenteric vein if the size is too long.Hence,a “stent within a stent” is a minor modification of this technique that allows customization for the size of the liver.In this technique,a fully covered graft stent (10 mm × 3-7 cm) is placed inside the bare uncovered stent (10 mm × 8-10 cm).

    Modified TIPSS/DIPS (direct intrahepatic portosystemic shunt)

    Long-segment (> 5 cm) HV block is usually not amenable to angioplasty,stenting,or TIPSS.A modified TIPSS or DIPS is a procedure where a shunt is made between IVC and the right branch of the portal vein.Though technically challenging,DIPS has been shown to effectively decompress hepatic congestion and clinical resolution in patients with BCS.In a large pediatric study from the authors’ center,children with chronic BCS undergoing DIPS had a procedural success and clinical response rate of 80% and 90%,respectively[15].

    Surgical shunts

    The principle of a surgical portosystemic shunt is to relieve the obstruction causing PHTN using a venous conduit,thereby decompressing the hepatic sinusoids.Surgical portosystemic shunts have now been almost completely abandoned because of high perioperative mortality (25%) and poor shunt patency (70%)[63-65].Surgical portosystemic shunting can also be technically difficult when there is caudate lobe hypertrophy[66].Most studies on surgical portosystemic shunts in adult patients with BCS failed to show any survival benefit[65,67].In a case series of 25 Indian children with BCS,only one out of the four patients who underwent surgical shunts survived[68].

    LT

    LT is considered a salvage therapy in the setting of fulminant presentation,progression to end-stage liver disease,or development of HCC[27,53].BCS accounts for approximately 1% of all pediatric LT cases[69].Involvement of retrohepatic IVC,the proximity of thrombus near the right atrium,and an underlying prothrombotic condition causing vascular complications make LT challenging.The challenge is even greater when considering living donor liver transplantation(LDLT) since the graft does not contain the retrohepatic IVC,as in deceased-donor liver transplantation (DDLT).Therefore,HV reconstruction is more complex,especially if the IVC is also obliterated[69].The smaller size of vessels in children complicates the situation further.Several large retrospective analyses have evaluated the benefit of DDLT in adult BCS patients with 5-year survival rates varying between 71% and 89.4%,similar to those undergoing LT for other diseases[70,71].Due to the scarcity of deceased-donor liver grafts,LDLT has been the mainstay for BCS patients undergoing LT in most Asian countries with 5-year survival rates ranging from 75% to 81%[72-75].Data on LT in pediatric BCS is only in the form of case reports and small case series and long-term prognosis has been reported to be good so far[76,77].

    STEPWISE APPROACH OR UPFRONT REI IN CHILDREN WITH BCS: THE WAY FORWARD?

    The rarity of BCS in general makes it difficult to perform randomized controlled trials in patients with BCS.Hence,most recommendations regarding treatment are based on case reports,retrospective studies,and expert opinions.Concerning the timing of the interventions,the European Association for the Study of the Liver[78] and the Asia Pacific Association for the Study of the Liver (APASL)[27] recommended a stepwise therapeutic algorithm for BCS in adults.The algorithm depends on treatment response,medical therapy with anticoagulant drugs,angioplasty,stent placement,TIPS,and LT.In contrast to the strict step-up principle,an AASLD practical guideline suggested checking for a venous obstruction amenable for angioplasty in all symptomatic patients right at the beginning and treating accordingly[79].The step-up algorithm has also been criticized because it pays little attention to hemodynamics and its possible improvement or even relief by interventional treatment.The step-up algorithm also does not restore physiology at the onset and possibly delays the definitive procedure,leading to advanced liver disease.Guidelines are silent regarding what should be the optimal treatment approach in children with BCS.Longitudinal studies on pediatric BCS have shown that children with chronic BCS tend to decompensate early with ascites and variceal bleeding[13,14].In those receiving medical therapy alone,it has been seen that 26% of adults die over 2 years[53,55].Response to medical therapy has been variable in children (33-43%)and two-thirds of these children ultimately require an intervention in the long run[14].There is also concern about the safety profile of long-term use of oral anticoagulants in children[80].Hence,we suggest that all children with BCS(whether symptomatic or not) should undergo angioplasty and stenting as a primary treatment modality.

    It is debatable whether asymptomatic or incidentally detected BCS should be subjected to REI or not,especially in children.On one hand,decompensation may rapidly set in as children do not tolerate portal hypertension for longer periods as compared to adults.On the other hand,there are no sound ethical justifications as to whether these children should be subjected to invasive procedures and maintained on lifelong anticoagulation.In a personal opinion,the authors would prefer the former in asymptomatic children given their longer life expectancy,milder liver disease,and possibly better health and compliance with the HV.Hence there is a small window of opportunity to restore normal physiology in optimal conditions.

    POST-INTERVENTION COMPLICATIONS AND NEED FOR MONITORING AFTER REI

    Immediate complications of REI include subcapsular hematoma,hemoperitoneum,congestive heart failure,transient hepatic encephalopathy,and pulmonary thromboembolism and are encountered in 1%-3% of procedures in experienced centers[12-16,27].Long-term complications of bleeding secondary to anticoagulation have also been reported[12,13,22].However,the most commonly encountered post-procedure complication is re-stenosis after REI.Singhet al[15],in a large cohort of Indian children with BCS,reported follow-up vascular patency rates of 87%,82%,and 62% at 1,5,and 10 years after intervention,respectively.In the above study,29% of the cohort with REI (27% HV/IVC stenting;60% modified TIPSS) had restenosis[15].Adult studies report 17% to 41% restenosis after REI[21,22,24].To prevent re-stenosis,heparin infusion should be started during the intervention and continued thereafter.Warfarin must be initiated within 24 h of completing the procedure.The physician should consider stopping heparin and continuation of long-term warfarin if the target INR of 2-3 is achieved.Periodic clinical examination,liver function test,and shunt patency by DUS (post-stenting:24 h,1 wk,1 mo,3 mo,and subsequently every 6 mo;post TIPS/DIPS: at 7-14 d,3 mo,6 mo,9 mo,and 12 mo) is performed.Post-intervention surveillance aims to re-intervene before critical stenosis or occlusions recur.

    Assessment of response to therapy

    Response to therapy implies restoration of blood flow across previously blocked HV/IVC and consequent improvement in organomegaly and liver function test (LFT),no recurrence of ascites without need of diuretics,and resolution of signs of PHTN.Kathuriaet al[13],in a study among 20 children with BCS undergoing REI,demonstrated clinical and biochemical resolution in all;however,the median follow-up duration was 6.5 mo only.Sharmaet al[14],in another study of 20 Indian children with BCS who underwent REI,showed that HV stenting or TIPS is efficacious in improving clinical features,LFT,PHTN features,and growth parameters in 66% and 72% of cases,respectively,over a median follow-up duration of 44 (range 5-132) mo.Further long-term studies need to holistically address the natural history and timelines of resolution of organomegaly,liver stiffness,varices,liver functions,growth,pubertal maturity,and quality of life in children with BCS.

    LIVER AND SPLENIC STIFFNESS MEASUREMENT IN MONITORING

    Recently,liver stiffness measurement (LSM) and splenic stiffness measurement (SSM) have been extensively studied as potential non-invasive markers of hepatic and splenic fibrosis and congestion and hepatic venous pressure gradient in patients with chronic liver disease[81-84].LSM and SSM can be measured by various imaging techniques [transient elastography (TE),shear-wave elastography (SWE),and MR elastography].Fraquelliet al[82],in a study of 132 patients with chronic hepatitis B and C,showed that LSM and SSM measured by TE,were reliable in predicting significant fibrosis[odds ratio (OR)=5.2 and 4.6,respectively] and cirrhosis (OR=7.8 and 9.1,respectively).SSM of < 48 kPa by TE was useful in ruling out esophageal varices.In another study by the same authors in 186 chronic liver disease patients,LSM and SSM measured by SWE were equally effective and reliable in predicting significant liver fibrosis as compared to TE,with SWE having the advantage of applicability in patients with obesity or ascites[83].The latest Baveno VII guidelines recommended that all cases of clinically advanced chronic liver disease should undergo LSM testing[85].

    However,these tests are yet not standardized in children.Pediatric literature regarding LSM and SSM by elastography techniques is emerging.Chongsrisawaet al[86] reported significantly higher LSM in biliary atresia patients with esophageal varices than those without (37.72 ± 21.55vs10.97 ± 8.71 kPa,P< 0.001).Yoonet al[87] showed that an LSM value of > 18.4 kPa predicted clinically significant PH (CSPH) in children with CLD with a high sensitivity (87.5%) and specificity (84.0%).LSM has been used to monitor and assess treatment response in adult patients with BCS[88].In a study to assess short-and long-term outcomes in 32 Chinese adults with BCS undergoing REI,Wanget al[88] measured LSM using SWE at 2 d,3 mo,and 6 mo post-procedure.Mean LSM value before the procedure was 35.17 ± 10.60 kPa,which decreased to 15.36 ± 4.34 kPa and 15.68 ± 5.58 kPa at 3 mo and 6 mo post-procedure,respectively (P< 0.001).Published literature on the role of LSM in monitoring children with BCS is scarce[89].Dohareet al[89] evaluated the role of LSM in 32 children undergoing REI and showed that LSM values decreased significantly after REI.A maximal decrease is seen 24 h after REI (43.7 kPa at baselinevs22.5 kPa 24 h post-procedure,P=0.001)[75].Among the nine children developing re-stenosis after REI,re-stenosis was typically associated with an increase in LSM compared with the patient's prior measurement (median absolute increase 11.0 kPa;interquartile range [IQR] 6.1-24.4).

    SSM reflects congestion as well as structural changes in the spleen as a direct consequence of the increased PHT[90,91].SSM is considered a direct and more suitable surrogate marker of PHTN and performs better for the prediction of CSPH[91,92] and esophageal varices[93,94].Suttonet al[94] evaluated SSM in 67 children with chronic liver disease and showed that SSM is a reliable predictor of CSPH at a value > 38.0 kPa [area under receiver operating curve (AUROC)=0.92,sensitivity=89%,specificity=82%,P< 0.01].Sintuseket al[95] studied 51 BA children and showed a higher SSM of 46.85(IQR 25.95-54.55) kPa in patients with varices as compared to the no-varices group [median SSM-16.54 (IQR 11.75-21.75)kPa;P< 0.001].SSM has been performed in adults with BCS (n=7) who underwent TIPSS[96].In this case series,SSM in combination with LSM may reflect the severity of the disease at presentation and the need for invasive treatment.SSM values also showed a significant decline after TIPSS over a median follow-up period of 1 year.Further studies are required to elucidate the role of LSM and SSM in monitoring BCS patients after REI.

    PROGNOSTIC INDICES AND THEIR IMPLICATIONS

    To date,many prognostic scores have been developed in patients with BCS to quantify the disease severity and prognosis(Table 3).The authors evaluated the prognostic accuracy of these indices in BCS children and found that pre-intervention PELD score with a cut-off of 4 (AUROC=0.809,86% sensitivity,and 75% specificity) significantly determined poor outcomes following REI.Zeitoun score independently predicted poor outcome [OR=15.4,95% confidence interval (CI):1.17-203.56,P=0.04] with a cut-off of 4.3 (AUROC=0.923,83% sensitivity,and 77% specificity) in the unintervened chronic BCS[15].Hence BCS children with a Zeitoun index > 4.3 should undergo REI without any delay.

    LONG-TERM COMPLICATIONS OF BCS

    Hepatopulmonary syndrome

    Hepatopulmonary syndrome (HPS) occurs in a substantial portion (28%) of adult patients with BCS and balloon angioplasty can reverse HPS in patients with BCS[97].The mechanism is unknown but may be related to portal decompression.This may also explain the favorable outcomes of TIPSS creation for HPS in patients with cirrhosis and idiopathic PHTN[98].Sharmaet al[14] in a previous pediatric study reported the detection of HPS among five children in long-term follow-up,one in an un-intervened child and four after RI with patent stent (3 TIPSS,1 HV angioplasty).It is not clear as to which patients will have resolution or progress to HPS as contradicting outcomes have been noted.The possible reason for developing HPS even after reduction of portal hypertension post-RI could be increased exposure of pulmonary vasculature to vasodilator mediators like increased levels of nitric oxide,endothelin-1,tumor necrosis factor-α,and endotoxemia[98].

    HCC is an uncommon but dreaded long-term complication of BCS[99,100].In a recent systematic review of adults,the prevalence of HCC in BCS is geographically varied[99].It is documented as 2.0%-46.2% in 12 Asian studies,40.0%-51.6%in two African studies,11.3% in one European study,and 11.1% in one American study[99].Irrespective of hepatitis as the underlying risk factor of HCC,the pooled prevalence of HCC was 17.6% in BCS patients (95%CI: 10.1%-26.7%),26.5%in IVC obstruction (95%CI: 14.4%-40.7%),and 4.2% in HV obstruction (95%CI: 1.6%-7.8%).When patients with HCC and concomitant hepatitis were excluded,the pooled prevalence of HCC was 15.4% (95%CI: 6.8%-26.7%).Only 3 out of the 16 included studies evaluated the risk factors for the development of HCC in BCS patients.However,there was significant heterogeneity among these studies and the results were contradicting[99].Further long-term prospective studies are necessary to evaluate risk factors for HCC in BCS patients.Data regarding the prevalence of HCC in children with BCS is limited.So far,only three cases of HCC in children with BCS have been reported[14,32,101].All of them had HCC in the 2nddecade of life,liver nodules > 3 cm,and elevated alpha-fetoprotein.One patient was on anticoagulation only[101]while the other two had blocked stents[14,32].In the authors’ own unpublished experience from the authors' center,an 18-year-old boy developed HCC 6 years after blockage of DIPS.Routine surveillance for HCC is thus warranted in BCS patients,even after undergoing REI.

    FUTURE DIRECTIONS

    Future studies need to elucidate the underlying thrombophilic conditions and their role in the etiopathogenesis of BCS.The use of next-generation sequencing in addition to the conventional thrombophilia work-up is warranted for better understanding and higher diagnostic yield.Further studies are needed to determine the precise role of MRA in differentiating benign liver nodules with HCC in BCS patients.Liver and splenic stiffness measurement by elastography techniques (transient elastography,shear-wave elastography,and MR elastography) may serve as a useful non-invasive marker for assessing treatment response.Despite its rarity,pediatric BCS provides a unique opportunity to study the natural history,long-term complications,and treatment outcome.

    CONCLUSION

    BCS is a rare but potentially treatable cause of portal hypertension with an excellent prognosis after definitive treatment.Due to recent advances in interventional radiology,radiological endovascular intervention is currently the preferred primary treatment modality.Better patient and procedure selection,choice of appropriate size and type of stent,and mandatory follow-up assessment are of utmost importance for better long-term outcomes.In future,prospective and larger studies should be undertaken to study the epidemiology and establish standardized diagnostic and therapeutic management protocols for pediatric BCS.

    FOOTNOTES

    Author contributions:Samanta A contributed to literature review,analysis,data collection and interpretation,and drafting of the initial manuscript;Sen Sarma M contributed to the conception and design of the manuscript,interpretation of the data,and critical revision of the initial manuscript;Yadav R contributed to interpretation of the data and the critical revision of the initial manuscript;all the authors approved the final version of the manuscript.

    Conflict-of-interest statement:All the authors declare no conflict of interest for this article.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers.It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license,which permits others to distribute,remix,adapt,build upon this work non-commercially,and license their derivative works on different terms,provided the original work is properly cited and the use is non-commercial.See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:India

    ORCID number:Arghya Samanta 0000-0002-1768-0263;Moinak Sen Sarma 0000-0003-2015-4069;Rajanikant Yadav 0000-0002-6955-850X.

    S-Editor:Liu JH

    L-Editor:Wang TQ

    P-Editor:Cai YX

    最新的欧美精品一区二区| 欧美精品亚洲一区二区| 免费黄网站久久成人精品| 蜜桃久久精品国产亚洲av| 日韩一区二区视频免费看| 伦理电影大哥的女人| 最新的欧美精品一区二区| 午夜激情久久久久久久| 天美传媒精品一区二区| 国产亚洲一区二区精品| 国产在线男女| 伊人亚洲综合成人网| 亚洲精品乱久久久久久| 男人爽女人下面视频在线观看| 日日啪夜夜爽| 你懂的网址亚洲精品在线观看| 日本与韩国留学比较| 黑人猛操日本美女一级片| 少妇猛男粗大的猛烈进出视频| av免费观看日本| 免费观看a级毛片全部| 久久ye,这里只有精品| 99久久综合免费| 女的被弄到高潮叫床怎么办| 亚洲精华国产精华液的使用体验| 亚洲精品,欧美精品| 在线看a的网站| 亚洲一区二区三区欧美精品| 在线观看国产h片| 简卡轻食公司| 日韩精品免费视频一区二区三区 | 欧美丝袜亚洲另类| 亚洲,欧美,日韩| 这个男人来自地球电影免费观看 | 国产成人aa在线观看| 日韩视频在线欧美| 天堂中文最新版在线下载| 久久久久久伊人网av| 亚洲成人手机| 国产乱人偷精品视频| 性高湖久久久久久久久免费观看| 丰满人妻一区二区三区视频av| 精品卡一卡二卡四卡免费| 亚洲精品国产av蜜桃| 人妻一区二区av| 日日啪夜夜撸| 啦啦啦中文免费视频观看日本| 性色av一级| 国产精品不卡视频一区二区| 国产熟女午夜一区二区三区 | 欧美精品亚洲一区二区| av专区在线播放| 寂寞人妻少妇视频99o| 国产欧美另类精品又又久久亚洲欧美| 人妻少妇偷人精品九色| 免费看不卡的av| 久久免费观看电影| 中国国产av一级| av女优亚洲男人天堂| 久久国产精品男人的天堂亚洲 | 男女无遮挡免费网站观看| 午夜福利影视在线免费观看| 国产欧美日韩一区二区三区在线 | 人人澡人人妻人| 热re99久久国产66热| 一本久久精品| 天堂俺去俺来也www色官网| 乱人伦中国视频| 赤兔流量卡办理| .国产精品久久| 亚洲一区二区三区欧美精品| 精品国产一区二区久久| 免费久久久久久久精品成人欧美视频 | 欧美精品一区二区大全| 一区二区av电影网| 中文字幕精品免费在线观看视频 | 成年av动漫网址| av有码第一页| 亚州av有码| 亚洲精品日本国产第一区| 久久国产精品男人的天堂亚洲 | 亚洲电影在线观看av| 一本—道久久a久久精品蜜桃钙片| 夜夜骑夜夜射夜夜干| 久久久a久久爽久久v久久| av.在线天堂| 亚洲电影在线观看av| 搡女人真爽免费视频火全软件| av在线app专区| .国产精品久久| 十分钟在线观看高清视频www | 伦理电影大哥的女人| 极品人妻少妇av视频| 最后的刺客免费高清国语| 久久久国产欧美日韩av| 欧美xxⅹ黑人| 国产精品免费大片| 91精品国产九色| 九草在线视频观看| 日韩中文字幕视频在线看片| 国产日韩欧美视频二区| 亚洲性久久影院| 少妇被粗大猛烈的视频| 精品少妇久久久久久888优播| 美女视频免费永久观看网站| 国产av码专区亚洲av| 美女国产视频在线观看| 中文乱码字字幕精品一区二区三区| 精品久久久噜噜| 亚洲av欧美aⅴ国产| 成人特级av手机在线观看| 三级国产精品片| 日韩成人伦理影院| 亚洲国产av新网站| 热99国产精品久久久久久7| 久久精品熟女亚洲av麻豆精品| 男女啪啪激烈高潮av片| 久久精品久久精品一区二区三区| 亚洲精品一区蜜桃| 国产精品人妻久久久久久| 日产精品乱码卡一卡2卡三| 日韩三级伦理在线观看| 成年人午夜在线观看视频| 青春草视频在线免费观看| av.在线天堂| 美女大奶头黄色视频| 最近最新中文字幕免费大全7| 18禁在线无遮挡免费观看视频| 午夜影院在线不卡| a级毛片在线看网站| 国产综合精华液| 高清毛片免费看| 日本免费在线观看一区| 久久午夜综合久久蜜桃| 久久精品国产鲁丝片午夜精品| 成年美女黄网站色视频大全免费 | 三级国产精品片| 岛国毛片在线播放| 亚洲欧洲日产国产| 亚洲av不卡在线观看| 国产男女超爽视频在线观看| 亚洲精品国产色婷婷电影| 亚洲精品中文字幕在线视频 | 人人妻人人添人人爽欧美一区卜| 蜜桃久久精品国产亚洲av| 日本-黄色视频高清免费观看| 国产亚洲午夜精品一区二区久久| 久热久热在线精品观看| 国产男女超爽视频在线观看| 日韩中文字幕视频在线看片| 亚洲高清免费不卡视频| 大香蕉久久网| 精品熟女少妇av免费看| 国产精品秋霞免费鲁丝片| av又黄又爽大尺度在线免费看| 热99国产精品久久久久久7| 精品99又大又爽又粗少妇毛片| 精品视频人人做人人爽| 欧美最新免费一区二区三区| 国产午夜精品久久久久久一区二区三区| 欧美精品国产亚洲| 最近手机中文字幕大全| 欧美日韩亚洲高清精品| 欧美老熟妇乱子伦牲交| 一级,二级,三级黄色视频| 精品久久久久久久久av| 国产在视频线精品| 亚洲不卡免费看| 亚洲,欧美,日韩| 国产黄频视频在线观看| av一本久久久久| 三级国产精品片| 黄色日韩在线| 少妇的逼好多水| 欧美3d第一页| 日本免费在线观看一区| 综合色丁香网| 国产高清三级在线| 只有这里有精品99| av国产精品久久久久影院| 狂野欧美白嫩少妇大欣赏| 99热这里只有是精品在线观看| 国产免费又黄又爽又色| 少妇高潮的动态图| 国产午夜精品久久久久久一区二区三区| 亚洲欧洲精品一区二区精品久久久 | 香蕉精品网在线| 欧美+日韩+精品| 最新的欧美精品一区二区| 多毛熟女@视频| 一本一本综合久久| 在线观看人妻少妇| 免费av不卡在线播放| 日本wwww免费看| 美女福利国产在线| 三上悠亚av全集在线观看 | 久久99热6这里只有精品| 久久女婷五月综合色啪小说| 亚洲精品国产色婷婷电影| 亚洲不卡免费看| 日韩一本色道免费dvd| 午夜福利视频精品| 欧美人与善性xxx| 亚洲自偷自拍三级| 久久精品国产鲁丝片午夜精品| 亚洲精品自拍成人| 99久久精品国产国产毛片| 欧美老熟妇乱子伦牲交| 日韩av免费高清视频| 晚上一个人看的免费电影| 久久人妻熟女aⅴ| 人人澡人人妻人| 又黄又爽又刺激的免费视频.| 欧美亚洲 丝袜 人妻 在线| 午夜福利影视在线免费观看| 伦精品一区二区三区| 大码成人一级视频| 中文字幕免费在线视频6| 伦理电影免费视频| av在线app专区| 一区二区三区精品91| 我要看黄色一级片免费的| 免费看不卡的av| 亚洲美女视频黄频| 麻豆精品久久久久久蜜桃| 大陆偷拍与自拍| 国产高清国产精品国产三级| 久久婷婷青草| 日韩制服骚丝袜av| 国产欧美日韩一区二区三区在线 | 成人特级av手机在线观看| 国产乱人偷精品视频| 亚洲精品,欧美精品| 大香蕉97超碰在线| 久久女婷五月综合色啪小说| av在线播放精品| 夜夜爽夜夜爽视频| 丰满人妻一区二区三区视频av| 国产一级毛片在线| 精品国产露脸久久av麻豆| 97超视频在线观看视频| 国语对白做爰xxxⅹ性视频网站| 一级av片app| 亚洲欧美成人精品一区二区| 久久久亚洲精品成人影院| 好男人视频免费观看在线| 国产又色又爽无遮挡免| 久久久久视频综合| 18禁动态无遮挡网站| 欧美精品一区二区大全| 99久国产av精品国产电影| 伊人久久精品亚洲午夜| 成人漫画全彩无遮挡| 欧美一级a爱片免费观看看| 国内揄拍国产精品人妻在线| 妹子高潮喷水视频| a级毛片在线看网站| 最后的刺客免费高清国语| 高清视频免费观看一区二区| 成人影院久久| 精品一区二区三卡| 十分钟在线观看高清视频www | 亚洲精品日韩在线中文字幕| 在线 av 中文字幕| 高清午夜精品一区二区三区| 国模一区二区三区四区视频| 看十八女毛片水多多多| 最近中文字幕高清免费大全6| 国产av一区二区精品久久| 18禁裸乳无遮挡动漫免费视频| 香蕉精品网在线| 亚洲精品视频女| 亚洲综合精品二区| 成人免费观看视频高清| 一级毛片久久久久久久久女| 在线播放无遮挡| 亚洲自偷自拍三级| tube8黄色片| 日韩中字成人| 超碰97精品在线观看| 日韩av不卡免费在线播放| 最后的刺客免费高清国语| 成年人免费黄色播放视频 | 成人美女网站在线观看视频| 国产精品国产三级国产av玫瑰| 女的被弄到高潮叫床怎么办| 免费人妻精品一区二区三区视频| 亚洲欧美中文字幕日韩二区| 亚洲欧美一区二区三区黑人 | 亚洲精品乱码久久久久久按摩| 午夜福利影视在线免费观看| 精品国产一区二区三区久久久樱花| 日韩成人av中文字幕在线观看| 赤兔流量卡办理| 欧美精品国产亚洲| 国产免费又黄又爽又色| 大码成人一级视频| 免费少妇av软件| 亚洲伊人久久精品综合| 一级av片app| 亚洲真实伦在线观看| 成年人午夜在线观看视频| 精品国产露脸久久av麻豆| 卡戴珊不雅视频在线播放| 国产精品不卡视频一区二区| 黑人猛操日本美女一级片| 欧美一级a爱片免费观看看| 日本vs欧美在线观看视频 | 精品午夜福利在线看| 高清在线视频一区二区三区| 久久久久久伊人网av| 亚洲人成网站在线播| 一区二区三区精品91| 国产美女午夜福利| 亚洲激情五月婷婷啪啪| 精品人妻熟女av久视频| 在线观看av片永久免费下载| 国产黄色视频一区二区在线观看| 男的添女的下面高潮视频| 日本欧美国产在线视频| 免费av不卡在线播放| 91精品国产国语对白视频| 亚洲精品一二三| 精品一区二区免费观看| 国产精品嫩草影院av在线观看| 青春草视频在线免费观看| 亚洲av中文av极速乱| 男女边吃奶边做爰视频| 在线免费观看不下载黄p国产| 亚洲无线观看免费| av在线观看视频网站免费| 国产成人a∨麻豆精品| 中文资源天堂在线| 各种免费的搞黄视频| 久久久久久久大尺度免费视频| 国产精品一区二区性色av| 91精品伊人久久大香线蕉| 99久久精品一区二区三区| 熟女电影av网| 国产综合精华液| 精品一区二区三卡| 国产成人91sexporn| 天堂俺去俺来也www色官网| 插逼视频在线观看| 国产国拍精品亚洲av在线观看| 少妇 在线观看| 成人亚洲欧美一区二区av| 亚洲,一卡二卡三卡| 成人综合一区亚洲| 国产亚洲5aaaaa淫片| 一本久久精品| 99re6热这里在线精品视频| 久久久久久久久大av| 国产精品嫩草影院av在线观看| 不卡视频在线观看欧美| 最黄视频免费看| 夜夜骑夜夜射夜夜干| 国产精品不卡视频一区二区| 日韩制服骚丝袜av| 99热全是精品| 国产av精品麻豆| 国产综合精华液| 夜夜爽夜夜爽视频| 日本av免费视频播放| 一二三四中文在线观看免费高清| 亚洲精品乱码久久久v下载方式| 亚洲精品亚洲一区二区| 国产片特级美女逼逼视频| 亚洲成色77777| 免费观看性生交大片5| 午夜影院在线不卡| 亚洲精品,欧美精品| 日韩亚洲欧美综合| 少妇高潮的动态图| 中国国产av一级| 成人综合一区亚洲| 亚洲欧美成人综合另类久久久| 麻豆精品久久久久久蜜桃| 制服丝袜香蕉在线| 91精品国产国语对白视频| kizo精华| 又粗又硬又长又爽又黄的视频| 成年女人在线观看亚洲视频| 日韩制服骚丝袜av| 亚洲精品中文字幕在线视频 | 国产男人的电影天堂91| 麻豆乱淫一区二区| 国产av精品麻豆| 久久人人爽av亚洲精品天堂| 亚洲国产毛片av蜜桃av| 一区在线观看完整版| 国产精品一区www在线观看| 久久久久久久久久久免费av| 成人影院久久| 99热这里只有是精品50| 99热国产这里只有精品6| 黄色视频在线播放观看不卡| 欧美最新免费一区二区三区| 国产日韩一区二区三区精品不卡 | 国产无遮挡羞羞视频在线观看| 国产免费福利视频在线观看| 午夜福利视频精品| 午夜福利,免费看| 一级片'在线观看视频| 欧美3d第一页| 天堂中文最新版在线下载| 99九九在线精品视频 | 午夜激情久久久久久久| 丝瓜视频免费看黄片| 日本与韩国留学比较| 国产一级毛片在线| 极品人妻少妇av视频| av在线老鸭窝| 有码 亚洲区| 蜜桃在线观看..| 欧美性感艳星| 欧美激情极品国产一区二区三区 | 美女xxoo啪啪120秒动态图| 亚洲性久久影院| 免费观看无遮挡的男女| 国产精品久久久久久久电影| 熟女人妻精品中文字幕| 街头女战士在线观看网站| 久久久久久久大尺度免费视频| 九九久久精品国产亚洲av麻豆| av在线老鸭窝| 91久久精品国产一区二区三区| 高清视频免费观看一区二区| 亚洲成人手机| 国产免费一级a男人的天堂| 最近2019中文字幕mv第一页| 亚洲天堂av无毛| 国产深夜福利视频在线观看| 国产亚洲91精品色在线| 熟女av电影| 亚洲欧美日韩卡通动漫| 色网站视频免费| 99久久精品国产国产毛片| 美女大奶头黄色视频| 韩国高清视频一区二区三区| 精品国产乱码久久久久久小说| 精品亚洲乱码少妇综合久久| 少妇的逼好多水| 中国美白少妇内射xxxbb| 国产精品女同一区二区软件| 欧美最新免费一区二区三区| av女优亚洲男人天堂| 欧美亚洲 丝袜 人妻 在线| 香蕉精品网在线| 日日撸夜夜添| 赤兔流量卡办理| 我要看日韩黄色一级片| 久久久久国产网址| 国模一区二区三区四区视频| 久久热精品热| 欧美日韩亚洲高清精品| 久久久久视频综合| 熟女av电影| 啦啦啦视频在线资源免费观看| 熟女电影av网| 亚洲精品成人av观看孕妇| 婷婷色综合大香蕉| 一级爰片在线观看| 99九九线精品视频在线观看视频| 久久女婷五月综合色啪小说| 欧美日韩av久久| 只有这里有精品99| 精品亚洲乱码少妇综合久久| 夫妻午夜视频| 大香蕉久久网| 成年人午夜在线观看视频| 亚洲精品,欧美精品| 亚洲美女搞黄在线观看| 在线观看三级黄色| 欧美+日韩+精品| 国模一区二区三区四区视频| 日韩av不卡免费在线播放| 久热久热在线精品观看| 免费不卡的大黄色大毛片视频在线观看| 人妻 亚洲 视频| 亚洲国产成人一精品久久久| 最黄视频免费看| 国产高清三级在线| 国产精品女同一区二区软件| 精品国产一区二区三区久久久樱花| 熟女人妻精品中文字幕| 久久国产乱子免费精品| 丁香六月天网| 青春草亚洲视频在线观看| 国产成人精品福利久久| 成年人午夜在线观看视频| 国产精品无大码| av在线app专区| 欧美另类一区| 成人亚洲精品一区在线观看| 黄色视频在线播放观看不卡| 日韩伦理黄色片| 成人美女网站在线观看视频| 成人18禁高潮啪啪吃奶动态图 | 久久久亚洲精品成人影院| 18禁动态无遮挡网站| av又黄又爽大尺度在线免费看| 尾随美女入室| 丰满少妇做爰视频| 免费高清在线观看视频在线观看| 久久精品国产鲁丝片午夜精品| 多毛熟女@视频| 少妇高潮的动态图| 国产 精品1| 少妇被粗大猛烈的视频| 久久精品熟女亚洲av麻豆精品| 久久青草综合色| 免费观看av网站的网址| 妹子高潮喷水视频| 日韩三级伦理在线观看| 亚洲无线观看免费| 美女cb高潮喷水在线观看| 在线观看免费日韩欧美大片 | 插逼视频在线观看| 美女cb高潮喷水在线观看| 欧美区成人在线视频| 成人无遮挡网站| 国产黄片美女视频| 美女内射精品一级片tv| 国产成人精品福利久久| 天堂8中文在线网| 高清视频免费观看一区二区| 伦理电影免费视频| 97超碰精品成人国产| 国产精品女同一区二区软件| 人妻一区二区av| 日日爽夜夜爽网站| 成人亚洲精品一区在线观看| 伦理电影免费视频| 一级爰片在线观看| 国产成人精品婷婷| 一级爰片在线观看| 又大又黄又爽视频免费| 妹子高潮喷水视频| 精品久久久久久久久亚洲| 久久久久久人妻| 国产成人免费观看mmmm| 免费少妇av软件| 亚洲欧洲日产国产| 日韩在线高清观看一区二区三区| 一级毛片久久久久久久久女| 亚洲欧美日韩东京热| 久久韩国三级中文字幕| av福利片在线观看| 在线免费观看不下载黄p国产| 精品一区二区免费观看| 日日摸夜夜添夜夜添av毛片| 国产亚洲精品久久久com| 亚洲精品日韩av片在线观看| 成年女人在线观看亚洲视频| 热re99久久国产66热| 这个男人来自地球电影免费观看 | 全区人妻精品视频| 亚洲精品中文字幕在线视频 | 中文字幕人妻熟人妻熟丝袜美| 成人特级av手机在线观看| 久久久久久久久久人人人人人人| 青春草国产在线视频| 久久久久视频综合| www.av在线官网国产| 最近2019中文字幕mv第一页| 国产成人免费观看mmmm| 亚洲在久久综合| 简卡轻食公司| 国产成人91sexporn| 人人妻人人爽人人添夜夜欢视频 | 亚洲成人av在线免费| 色视频www国产| 中文精品一卡2卡3卡4更新| 伦理电影大哥的女人| 国产中年淑女户外野战色| www.色视频.com| 伦精品一区二区三区| 男人爽女人下面视频在线观看| 人人妻人人澡人人看| 少妇裸体淫交视频免费看高清| 一级毛片黄色毛片免费观看视频| 国产精品久久久久久久久免| 国产亚洲欧美精品永久| 国产精品.久久久| 51国产日韩欧美| www.色视频.com| 高清视频免费观看一区二区| 曰老女人黄片| 一区二区av电影网| 人人妻人人爽人人添夜夜欢视频 | 美女脱内裤让男人舔精品视频| 性色av一级| 国产国拍精品亚洲av在线观看| 人人妻人人澡人人爽人人夜夜| 性色av一级| 午夜久久久在线观看| 精品国产一区二区三区久久久樱花| 男人狂女人下面高潮的视频| 夫妻午夜视频| 欧美日韩一区二区视频在线观看视频在线| 国产精品蜜桃在线观看| 国产精品欧美亚洲77777| 在线天堂最新版资源| 韩国高清视频一区二区三区| 国产伦精品一区二区三区视频9| 日韩视频在线欧美| 美女xxoo啪啪120秒动态图| 亚洲中文av在线| 男人和女人高潮做爰伦理| 在线观看av片永久免费下载| 亚洲欧美日韩另类电影网站| 日本色播在线视频| 免费黄频网站在线观看国产| 国产亚洲午夜精品一区二区久久|